entertainment -WSS

entertainment

author：comprehensive 2025-10-02 21:35:49 - browse：43912

Adobe

You didn’t need machine learning to make one prediction about the year’s biggest conference for health care investors, which was held in San Francisco last week. It was going to rain.

Recursion, a biotechnology firm that uses machine learning for drug development and that was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment. As the heavens opened, Recursion employees handed out black umbrellas emblazoned with the Recursion logo and lined with neon images of cells. It was one of a series of publicity grabs from the company, including a satellite event featuring Nvidia’s famous CEO, Jensen Huang, who has become a Wall Street rock star as his company’s stock has exploded due to rising expectations for AI, reaching a $1 trillion market value, the sixth highest in the world.

Seeing the square outside the Westin St. Francis, where the J.P. Morgan Healthcare Conference has been held for 42 years, fill with Recursion’s umbrellas was a little like seeing the message that AI was ready for its debut come to life. But it was also true that not everyone was ready to embrace that message.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

knowledge

WSS

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Goldman Sachs launches $650M fund for life science investments

Change Healthcare outage fallout shows need for new oversight

HHS secretary Becerra pressed on Change HealthCare cyberattack

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Wikipedia

entertainment

hotspot

Peter Hotez and the public health issue of online harassment

Amid AI frenzy, a top HHS official's quest to create safeguards

Dobbs anniversary: the lost opportunity of abortion as health care

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

ChatGPT in medicine: STAT answers readers' burning questions

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Cancer drug shortages should be causing more outrage

EPA limits use of carcinogenic gas for sterilizing medical devices

DIEP, the 'gold standard' of breast reconstruction, is under threat

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

hotspot

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

WuXi out of biotech trade group, U.S. and China relations to blame

Antibiotic resistance and the global rise in human conflict

Readout Newsletter: CAR

UCB departs biotech trade group BIO

HHS secretary Becerra pressed on Change HealthCare cyberattack

entertainment

leisure time

knowledge

leisure time